Skip to main content

Table 4 How and when to screen

From: Survey on patients’ organisations’ knowledge and position paper on screening for inherited neuromuscular diseases in Europe

Modality of screening

Number of answers

When should screening take place?

Number of answers

Systematic with the option to opt-out

21

At birth

9

  

Early pregnancy

6

  

Preconception

4

  

Depends on the disease and the situation

3

Systematic

4

At birth

2

  

Early pregnancy

1

  

Preconception

1

Not systematic with the possibility to opt-in

3

At birth

1

  

Depends on the disease and the situation

1

  

Preconception

1